Vor Biopharma (VOR) Accumulated Depreciation (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Accumulated Depreciation data on file, last reported at $53000.0 in Q1 2026.

• Accumulated Depreciation for Q1 2026 came in at $53000.0, down 99.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $53000.0 (down 99.56% YoY), and the FY2025 annual result was $25000.0, down 99.78% from the prior year.
• Accumulated Depreciation grew to $53000.0 in Q1 2026 per VOR's latest filing, from $25000.0 in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $12.0 million in Q1 2025 and troughed at $1000.0 in Q3 2025.
• A 5-year average of $5.9 million and a median of $5.9 million in 2023 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation soared 142.04% in 2022, then plunged 99.99% in 2025.
• A 5-year view of Accumulated Depreciation shows it stood at $4.6 million in 2022, then surged by 75.51% to $8.1 million in 2023, then jumped by 38.6% to $11.2 million in 2024, then slumped by 99.78% to $25000.0 in 2025, then jumped by 112.0% to $53000.0 in 2026.
• Business Quant data shows VOR's Accumulated Depreciation at $53000.0 in Q1 2026, $25000.0 in Q4 2025, and $1000.0 in Q3 2025.